• Grapheal raises EUR1.9 million to advance development of embedded biosensing technology and application in digital COVID testing and wound monitoring

    Wednesday February 10th 2021

  • Estelle® study results published in leading peer-reviewed medical journal

    Tuesday February 9th 2021

  • BISC Global launches its Online Pipeline Platform (OP²)

    Monday February 8th 2021

  • Life-saving TCR T-cell therapies for hard-to-treat solid tumors

    Monday February 8th 2021

  • Mithra's Board of Directors appoints Leon Van Rompay as CEO ad interim

    Friday February 5th 2021

  • Sequana Medical announces granting of key alfapump DSR® patents in U.S. and Europe

    Friday February 5th 2021

  • V-Bio Ventures launches its second fund at EUR 78 million

    Thursday February 4th 2021

  • VUB scientist Mathieu Vinken coordinates prestigious European research into animal-free methods for testing chemical substances

    Wednesday February 3rd 2021

  • Your news here?

  • New US studies demonstrate Idylla™ allows rapid first assessment of most common EGFR mutations preceding next-generation sequencing

    Wednesday February 3rd 2021

  • argenx announces “GO” Decision in ADHERE trial of Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy following interim analysis

    Tuesday February 2nd 2021

  • Euronext Biotech Barometer H2 2020

    Monday February 1st 2021

Strategic Partners